IART : Summary for Integra LifeSciences Holdings C - Yahoo Finance

U.S. Markets closed

Integra LifeSciences Holdings Corporation (IART)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
44.16-0.14 (-0.32%)
At close: 4:00PM EST
People also watch
ICUIWMGIHAECNMDNUVA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close44.30
Open44.57
Bid0.00 x
Ask0.00 x
Day's Range44.03 - 44.65
52 Week Range40.77 - 88.86
Volume1,099,565
Avg. Volume535,385
Market Cap3.3B
Beta0.66
PE Ratio (TTM)57.50
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters5 days ago

    Integra to buy J&J's Codman neurosurgery business for $1.05 bln

    Medical device maker Integra LifeSciences Holdings Corp said it would buy Johnson & Johnson's Codman neurosurgery business for $1.05 billion in cash, to expand its presence outside the United States. Integra, which makes products used in neurosurgery, reconstruction, wound and dental care, made a "binding offer" for the Codman business, which will bolster its pipeline of offerings for tissue ablation, spinal cord repair and cranial stabilization. The companies will finalize the deal after receiving the green light from various works councils and regulators, a J&J spokeswoman told Reuters, adding that the deal would close in the fourth quarter, if approved.

  • TheStreet.com5 days ago

    Integra Scoops Up JNJ's Codman Neurosurgery for $1.05 Billion

    The company hopes the JNJ assets will give revenue growth a boost.

  • The Wall Street Journal5 days ago

    [$$] Integra Bids $1.05 Billion for J&J Neurosurgery Business

    Integra LifeSciences Holdings has made an offer to buy Johnson & Johnson’s Codman Neurosurgery business for about $1.05 billion in cash.